author_facet Yang, Jing
Liu, Jiaochun
Chen, Yu
Tang, Weifeng
Bo, Kai
Sun, Yuling
Chen, Jianping
Yang, Jing
Liu, Jiaochun
Chen, Yu
Tang, Weifeng
Bo, Kai
Sun, Yuling
Chen, Jianping
author Yang, Jing
Liu, Jiaochun
Chen, Yu
Tang, Weifeng
Bo, Kai
Sun, Yuling
Chen, Jianping
spellingShingle Yang, Jing
Liu, Jiaochun
Chen, Yu
Tang, Weifeng
Bo, Kai
Sun, Yuling
Chen, Jianping
Bioscience Reports
Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
Cell Biology
Molecular Biology
Biochemistry
Biophysics
author_sort yang, jing
spelling Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20181824 <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&amp;gt;C, rs10932029 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&amp;gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&amp;gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&amp;gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&amp;gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> Investigation of <i>ICOS, CD28</i> and <i>CD80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population Bioscience Reports
doi_str_mv 10.1042/bsr20181824
facet_avail Online
Free
finc_class_facet Biologie
Chemie und Pharmazie
Physik
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA
institution DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
imprint Portland Press Ltd., 2019
imprint_str_mv Portland Press Ltd., 2019
issn 0144-8463
1573-4935
issn_str_mv 0144-8463
1573-4935
language English
mega_collection Portland Press Ltd. (CrossRef)
match_str yang2019investigationoficoscd28andcd80polymorphismswiththeriskofhepatocellularcarcinomaacasecontrolstudyineasternchinesepopulation
publishDateSort 2019
publisher Portland Press Ltd.
recordtype ai
record_format ai
series Bioscience Reports
source_id 49
title Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_unstemmed Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_full Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_fullStr Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_full_unstemmed Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_short Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_sort investigation of <i>icos, cd28</i> and <i>cd80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern chinese population
topic Cell Biology
Molecular Biology
Biochemistry
Biophysics
url http://dx.doi.org/10.1042/bsr20181824
publishDate 2019
physical
description <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&amp;gt;C, rs10932029 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&amp;gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&amp;gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&amp;gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&amp;gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p>
container_issue 7
container_start_page 0
container_title Bioscience Reports
container_volume 39
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792330374333857795
geogr_code not assigned
last_indexed 2024-03-01T13:23:38.16Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Investigation+of+ICOS%2C+CD28+and+CD80+polymorphisms+with+the+risk+of+hepatocellular+carcinoma%3A+a+case%E2%80%93control+study+in+eastern+Chinese+population&rft.date=2019-07-31&genre=article&issn=1573-4935&volume=39&issue=7&jtitle=Bioscience+Reports&atitle=Investigation+of+%3Ci%3EICOS%2C+CD28%3C%2Fi%3E+and+%3Ci%3ECD80%3C%2Fi%3E+polymorphisms+with+the+risk+of+hepatocellular+carcinoma%3A+a+case%E2%80%93control+study+in+eastern+Chinese+population&aulast=Chen&aufirst=Jianping&rft_id=info%3Adoi%2F10.1042%2Fbsr20181824&rft.language%5B0%5D=eng
SOLR
_version_ 1792330374333857795
author Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping
author_facet Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping, Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping
author_sort yang, jing
container_issue 7
container_start_page 0
container_title Bioscience Reports
container_volume 39
description <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&amp;gt;C, rs10932029 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&amp;gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&amp;gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&amp;gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&amp;gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p>
doi_str_mv 10.1042/bsr20181824
facet_avail Online, Free
finc_class_facet Biologie, Chemie und Pharmazie, Physik
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA0Mi9ic3IyMDE4MTgyNA
imprint Portland Press Ltd., 2019
imprint_str_mv Portland Press Ltd., 2019
institution DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1
issn 0144-8463, 1573-4935
issn_str_mv 0144-8463, 1573-4935
language English
last_indexed 2024-03-01T13:23:38.16Z
match_str yang2019investigationoficoscd28andcd80polymorphismswiththeriskofhepatocellularcarcinomaacasecontrolstudyineasternchinesepopulation
mega_collection Portland Press Ltd. (CrossRef)
physical
publishDate 2019
publishDateSort 2019
publisher Portland Press Ltd.
record_format ai
recordtype ai
series Bioscience Reports
source_id 49
spelling Yang, Jing Liu, Jiaochun Chen, Yu Tang, Weifeng Bo, Kai Sun, Yuling Chen, Jianping 0144-8463 1573-4935 Portland Press Ltd. Cell Biology Molecular Biology Biochemistry Biophysics http://dx.doi.org/10.1042/bsr20181824 <jats:title>Abstract</jats:title> <jats:p>Single nucleotide polymorphisms (SNPs) in immune related gene may influence the susceptibility of cancer. We selected inducible T cell costimulator (ICOS) rs4404254 T&amp;gt;C, rs10932029 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs and assessed the potential relationship of these SNPs with hepatocellular carcinoma (HCC) risk. A total of 584 HCC cases and 923 healthy controls were recruited. And SNPscan™ genotyping assay was used to obtain the genotypes of ICOS, CD28 and CD80 polymorphisms. We found that ICOS rs10932029 T&amp;gt;C polymorphism significantly increased the risk of HCC (additive model: adjusted odds ratio (OR), 1.59; 95% confidence interval (CI), 1.13–2.22; P=0.007; homozygote model: adjusted OR, 1.12; 95% CI, 0.31–4.03; P=0.867; dominant model: adjusted OR, 1.58; 95% CI, 1.14–2.19; P=0.007 and recessive model: adjusted OR, 1.02; 95% CI, 0.28–3.68; P=0.974). However, ICOS rs4404254 T&amp;gt;C, CD28 rs3116496 T&amp;gt;C and CD80 rs7628626 C&amp;gt;A SNPs were not associated with the risk of HCC. To evaluate the effects of ICOS rs10932029 T&amp;gt;C on HCC risk according to different age, gender, chronic hepatitis B virus (HBV) infection, tobacco consumption and drinking status, we carried out a stratification analysis. We found that ICOS rs10932029 T&amp;gt;C polymorphism might increase the risk of HCC in male, ≥53 years, never smoking, never drinking and non-chronic HBV infection subgroups. Our study highlights that ICOS rs10932029 T&amp;gt;C polymorphism may confer the susceptibility to HCC. It may be beneficial to explore the relationship between variants in immune related genes and the development of HCC.</jats:p> Investigation of <i>ICOS, CD28</i> and <i>CD80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population Bioscience Reports
spellingShingle Yang, Jing, Liu, Jiaochun, Chen, Yu, Tang, Weifeng, Bo, Kai, Sun, Yuling, Chen, Jianping, Bioscience Reports, Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population, Cell Biology, Molecular Biology, Biochemistry, Biophysics
title Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_full Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_fullStr Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_full_unstemmed Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_short Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
title_sort investigation of <i>icos, cd28</i> and <i>cd80</i> polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern chinese population
title_unstemmed Investigation of ICOS, CD28 and CD80 polymorphisms with the risk of hepatocellular carcinoma: a case–control study in eastern Chinese population
topic Cell Biology, Molecular Biology, Biochemistry, Biophysics
url http://dx.doi.org/10.1042/bsr20181824